杏林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4569/E00985 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/01/08 | 日証協 | 381,381株 | +24.31% | 53,175株 | +68.28% | 414,966株 | +6.98% | 12,775株 | -68.14% |
2015/12/30 | 日証協 | 306,806株 | -12.75% | 31,600株 | -47.04% | 387,893株 | -6.25% | 40,100株 | -28.75% |
2015/12/25 | 日証協 | 351,648株 | -37.13% | 59,664株 | -66.94% | 413,763株 | -27.46% | 56,281株 | -68.03% |
2015/12/18 | 日証協 | 559,348株 | +1.6% | 180,457株 | +64.38% | 570,406株 | +17.92% | 176,065株 | +361.12% |
2015/12/11 | 日証協 | 550,548株 | +23.04% | 109,778株 | +765.14% | 483,733株 | +0.81% | 38,182株 | -2.76% |
2015/12/04 | 日証協 | 447,448株 | -7.52% | 12,689株 | -82.18% | 479,844株 | -8.71% | 39,264株 | +50.23% |
2015/11/27 | 日証協 | 483,848株 | -6.55% | 71,200株 | -35.15% | 525,644株 | -9.41% | 26,136株 | -46.73% |
2015/11/20 | 日証協 | 517,748株 | -0.42% | 109,800株 | +581.99% | 580,244株 | +0.15% | 49,064株 | -8.01% |
2015/11/13 | 日証協 | 519,946株 | -6.21% | 16,100株 | -88.76% | 579,378株 | -3.94% | 53,336株 | +67.36% |
2015/11/06 | 日証協 | 554,346株 | -2% | 143,224株 | +916.57% | 603,170株 | -5.49% | 31,869株 | +4.75% |
2015/10/30 | 日証協 | 565,646株 | -1.65% | 14,089株 | +42.86% | 638,190株 | -1.22% | 30,425株 | +607.39% |
2015/10/23 | 日証協 | 575,157株 | +0.07% | 9,862株 | 0% | 646,075株 | -3.98% | 4,301株 | -92.55% |
2015/10/16 | 日証協 | 574,757株 | -0.85% | 0株 | -100% | 672,874株 | +0.23% | 57,699株 | +242.49% |
2015/10/09 | 日証協 | 579,668株 | +19.38% | 114,900株 | +39.36% | 671,344株 | +0.15% | 16,847株 | -66.71% |
2015/10/02 | 日証協 | 485,557株 | -2.67% | 82,448株 | +89.61% | 670,328株 | -28.53% | 50,605株 | -53.23% |
2015/09/25 | 日証協 | 498,885株 | +1.46% | 43,484株 | -89.14% | 937,917株 | +13.22% | 108,200株 | -86.56% |
2015/09/18 | 日証協 | 491,685株 | +36.04% | 400,511株 | +504.86% | 828,417株 | +53.12% | 805,353株 | +495.19% |
2015/09/11 | 日証協 | 361,440株 | +0.92% | 66,215株 | +18.75% | 541,017株 | -14.26% | 135,311株 | +52.81% |
2015/09/04 | 日証協 | 358,131株 | +4.61% | 55,759株 | +216.81% | 630,981株 | -3.86% | 88,548株 | +433.42% |
※株式分割は考慮していませんのでご注意ください。
Page Top